Samantha Zullow
@SamZullowMD
Followers
663
Following
2K
Media
37
Statuses
264
Gastroenterologist and Inflammatory Bowel Disease specialist @BIDMC_GI, GI @NYUlangone @BellevueHosp, IM @BMCimRES, opinions my own
Boston, MA
Joined June 2017
RT @CCYANetwork: Research often lumps young adults into the 18–65 age group, ignoring crucial developmental and physiological differences.….
0
2
0
RT @BIDMC_GI: Colorectal cancer is the #1 cause of cancer death in men under 50. This is why #45istheNew50. Our team at #BIDMC_GI is he….
0
4
0
RT @BIDMC_GI: Stay proactive about your health! If you have IBD, you're at a higher risk of colorectal cancer. Talk to our team today about….
0
2
0
RT @SuhaAbushamma: Common scenario in IBD clinic answered by @sidbarritt4 . 💎 Isolated HBcAb pts on anti-TNF agents are considered low risk….
0
7
0
#AIBD2024 Algorithm for management for asymptomatic ileitis (incidentally diagnosed terminal ileitis "IDTI" on screening colonoscopy) @IBDConference @tinahamd
0
0
5
Excellent UP treatment algorithm; consider use of topical/rectal tacrolimus before moving on to other advanced therapy. Consider etrasimod given UP subgroup in clinical trials. #AIBD2024 @IBDConference
0
0
3
#AIBD2024 mod-severe UP subgroup seen in etrasimod study; improved outcomes compared to more extensive colitis @IBDConference @mchiorean4
0
0
1
#AIBD2024 clinical trials stopped early due to significant improvement on tacrolimus for refractory UP. Significant clinical and endoscopic improvement seen. @IBDConference @mchiorean4
0
1
8
Live from #AIBD2024: Some non-invasive IBD biomarkers are less reliable in ulcerative proctitis including intestinal ultrasound and fecal calprotectin @IBDConference @mchiorean4
0
0
4
UP risk factors for progression; it is important to explain to patients they have a risk for extension of disease. Up to 20% of pateints require treatment intensification to an advanced therapy.#AIBD2024 @IBDConference
0
0
1
Looking forward to presenting on April 1st about transition from peds to adult GI care for people with IBD! Hope to see you there @CCYANetwork @CCfdnNewEngland @PediatricIBD #GITwitter #IBD.
There is still time to register for MyIBD Learning Patient & Caregiver Education Conference on April 1st. We have an excellent line up of presentations. Tickets are $10 and scholarships are available!.View all of the details here:
1
1
11
RT @sonika_sethi: Our Meta‐analysis is out on @APandT The efficacy of therapeutic drug monitoring of anti‐TNF‐therapy in inflammatory bowel….
onlinelibrary.wiley.com
A systematic review and meta-analysis on the efficacy of therapeutic drug monitoring (TDM) of anti TNF-therapyin inflammatory bowel disease shows several benefits in using proactive TDM. Proactive...
0
29
0
Great advice for any #GI fellows interested in #IBD fellowship! Reach out to me if you're interested in @BIDMC_GI for IBD fellowship in the future.
📣 Calling all future #IBD fellows! . 🍁 Check out our new article in the FALL issue of #ACGMagazine @AmCollegeGastro . Big thank you to our incredible faculty and fellows for their insightful, entertaining and inspiring advice! #BOOM 🔥🫶🏻🌟. ⬇️ MUST DO’S for #IBD fellowship! 1/
1
3
15
RT @IBDJournals: In this article, @IBD_Houston examines safety data on ustekinumab in 🤰. In this cohort of 39 #IBD pregnancies:.🚫 no speci….
academic.oup.com
AbstractBackground. While no adverse developmental outcomes were observed in preclinical animal studies, limited data exist regarding effects of ustekinuma
0
9
0
RT @UmaMahadevanIBD: Results from PAPooSE group on 82 pregnancies among 77 IBD stoma pts. These are high risk pts needing MFM monitoring. @….
0
12
0
RT @DrLorenGR: New article @HarvardHealth on #Familyplanning 🫃with #IBD:.▶️Remission before conception is🔑.▶️Assemble your care team 👨⚕️….
www.health.harvard.edu
Inflammatory bowel disease is commonly diagnosed at a point in life when many people are planning families. People who have been diagnosed with IBD are likely to have questions and concerns ...
0
2
0
RT @GI_PharmD: (1/13)📢 New med option for mod to severe Crohn's disease:.Risankizumab-rzaa (Skyrizi) - IL23 antagonist . 🏥 Induction: 600 m….
0
84
0
RT @NEJMEvidence: This #RCT evaluated infliximab withdrawal in pts with #Crohns disease in remission on infliximab maintenance therapy. Tim….
0
31
0